A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database
NCT06962969
·
clinicaltrials.gov ↗
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced or Metastatic Breast Cancer
Interventions
DRUG:
Ibrance
Sponsor
Pfizer